Search

The Delaware Senate has approved cannabis attorney and lobbyist Joshua Sanderlin to lead the state's Office of the Marijuana Commissioner. New Delaware marijuana commissioner taking reins as adult-use launch looms is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs < Back New Delaware marijuana commissioner taking reins as adult-use launch looms May 20, 2025 Margaret Jackson MJ Biz Daily Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link The Delaware Senate has approved cannabis attorney and lobbyist Joshua Sanderlin to lead the state's Office of the Marijuana Commissioner. New Delaware marijuana commissioner taking reins as adult-use launch looms is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

Senator Says It’s ‘Extremely Concerning’ Trump Has Delayed Marijuana Rescheduling After Pledging Action Two Months Ago < Back Senator Says It’s ‘Extremely Concerning’ Trump Has Delayed Marijuana Rescheduling Oct 20, 2025 Kyle Jaeger Marijuana Moment Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link A Democratic senator says it’s “extremely concerning the Trump administration continues to drag its feet” on a marijuana reform—including the pending cannabis rescheduling decision that the president said in August would be decided on within weeks. By delaying action on the plan to move cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA), the administration is “perpetuating the injustices of the failed war on drugs,” Sen. Ron Wyden (D-OR) told Marijuana Moment on Friday. “Whether it’s lowering prescription drug costs, protecting health care, or bringing our nation’s cannabis laws into the 21st century, Donald Trump’s presidency is one big broken promise,” he said. “I’ll continue to work with my colleagues in the Senate to press the administration to get with the program and meet the overwhelming majority of American voters where they are on this issue.” Reclassifying cannabis as a Schedule III drug wouldn’t federally legalize it, but it would recognize the medical value of marijuana, free up certain research barriers associated with Schedule I drugs and allow licensed cannabis businesses to take federal tax deductions they’ve been barred from under Internal Revenue Service code 280E. Polls have shown bipartisan support for that policy change, but a majority of Americans also support ending prohibition altogether. Trump endorsed rescheduling—as well as cannabis industry banking access and a Florida legalization ballot initiative that fell short last year—but he hasn’t gotten behind federal legalization. Trump’s latest comments on the timeline for rescheduling also lacked a clear signal that he intended to move forward with a Schedule III reclassification, even though he pledged to do so last year during his presidential campaign. Wyden, as well as two other GOP senators, additionally weighed in on rescheduling and bipartisan marijuana banking reform legislation in interviews with Marijuana Moment on Thursday. The Democratic senator said rescheduling would send a “huge message” to his colleagues about the need to “finally come up with a modern approach” to marijuana laws. “I’d like it a lot. I mean, it would set up the path to getting into a store and all the areas where there’s consumer demand,” he said, adding that Trump has “been all over the map on this, but I hope he’ll want to help work out the market.” “There are a lot of senators that are ready for it,” he said. Sen. Steve Daines (R-MT), who’s been the lead GOP sponsor of the cannabis banking measure in past sessions, said he’s “not sure absolutely” whether the president rescheduling marijuana would move the needle within the Republican caucus. “Many senators hold strong opinions,” and “they keep those opinions separate from SAFE Banking,” he said. “I’m not a fan of recreational marijuana. I voted against it in Montana, but it passed. But I definitely support SAFE Banking and taking that cash off the streets, and put it into banks,” Daines said. “It’s the right thing to do.” Sen. Dan Sullivan (R-AK), for his part, said he’s “not tracking” developments on rescheduling, and he suggested that his constituents have not been especially vocal in their outreach to his office about the issue. “My view is we have to just [pass] the Banking Act,” he said. “I mean, that’s the one that’s got a lot of bipartisan support.” Sen. Bernie Moreno (R-OH) told AskAPol last month that he did feel that Trump advancing rescheduling would be an “important domino” to advance the bipartisan cannabis banking legislation. The senator, who is expected to be the lead sponsor of the legislation this Congress, previously said that the Secure and Fair Enforcement Regulation (SAFER) Banking Act would be taken up this fall. “We’re still seeing what we can do to get it done in Q4,” Moreno said. “As you know, the Democrats give us a lot of stuff to do. We have to fund the government, we have to get [the National Defense Authorization Act, or NDAA] across the finish line. We’ve gotta get [Trump’s judicial nominations] done.” Separately, the president last month posted a video on his Truth Social platform promoting the health benefits of cannabis—suggesting that covering CBD under Medicare would be “the most important senior health initiative of the century.” *— Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.* *Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. —* Meanwhile, during a House Appropriations Committee markup last month, Rep. Betty McCollum (D-MN) criticized the exclusion of provisions to protect banks that work with state-licensed marijuana and hemp businesses from a key spending bill. Relatedly, a bipartisan coalition of 32 state and territory attorneys general from across the U.S. recently called on Congress to pass a marijuana banking bill to free up financial services access for licensed cannabis businesses. The Democratic Senate sponsor of the marijuana banking bill in past sessions, Sen. Jeff Merkley (D-OR), recently said that, despite efforts to coordinate meetings around the legislation, other priorities have taken precedence for now. In January, the office of Rep. Dave Joyce (R-OH), who is again leading the effort on the House, told Marijuana Moment that he would be filing the cannabis banking legislation this session but that its introduction was “not imminent” as some earlier reports had suggested. *The LCB contributed reporting from Washington, D.C. * *Photo courtesy of Philip Steffan.* The post Senator Says It’s ‘Extremely Concerning’ Trump Has Delayed Marijuana Rescheduling After Pledging Action Two Months Ago appeared first on Marijuana Moment. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

Cannabuzz, a Kentucky-based manufacturer of hemp-derived THC beverages, has joined the Wine & Spirits Wholesalers of America (WSWA) as an associate member, marking the first time an alcohol industry group has added a THC-infused drinks company to its roster. Cannabuzz aims to collaborate with WSWA to grow a safe and accessible market for THC beverages, focusing on standardized labeling, potency-appropriate serving sizes, and clear age-gating. WSWA has been advocating for a regulatory framework for hemp-based intoxicating cannabinoids, rather than a ban, and has pushed for policies like banning synthetic THC, establishing a federal testing and labeling system, and granting states power to regulate retail sales. Bipartisan House lawmakers are also working on an alternative measure to regulate the market, pushing back against attempts to ban hemp THC products. < Back Major Alcohol Industry Trade Association Welcomes Its First THC Cannabis Beverage Member Sep 30, 2025 Tom Angell Marijuana Moment Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link A leading alcohol industry group has added a company that makes THC-infused drinks to its membership roster for the first time. Cannabuzz, a Kentucky-based manufacturer of hemp-derived THC beverages, is now an associate member of Wine & Spirits Wholesalers of America (WSWA), the company announced in a press release last week. “We’re proud to be the first THC brand to join WSWA’s THC beverage category,” Annie Rouse, Cannabuzz CEO & Founder, said in a press release. “We look forward to collaborating with the organization and providing our industry expertise to help grow a safe and accessible market.” Being a part of WSWA will give Cannabuzz “access to distributor expertise, best-practice frameworks and policy engagement as the cannabis category matures,” the company said. “Our goal isn’t just to sell drinks—it’s to help retailers, distributors, and regulators align on simple guardrails that protect consumers and give stores confidence to stock the category,” Rouse said. “We believe standardized labeling, potency appropriate serving sizes and clear age-gating will define the next chapter of adult cannabis beverages. We’re excited to join beverage-alcohol’s leading trade group to help build these responsible standards for hemp-derived THC [ready-to-drink beverages].” WSWA staff did not respond to Marijuana Moment’s request for comment for this story, though the organization’s website confirms Cannabuzz is now an associate member of the organization. The association in June called on Congress to dial back language in a House spending bill that would ban most consumable hemp products, instead proposing to maintain the legalization of naturally derived cannabinoids from the crop and only prohibit synthetic items. Members of WSWA also met with lawmakers and staffers in April to advocate for three key policy priorities that the group says is based on “sound principles of alcohol distribution.” They include banning synthetic THC, setting up a federal system for testing and labeling products and establishing state-level power to regulate retail sales. In an op-ed for Marijuana Moment in June, WSWA President and CEO Francis Creighton said echoed that point, reiterating the organization’s position that regulation is superior to prohibition. This is also consistent with WSWA’s earlier message to House and Senate Agriculture Committee last session, where the association implored congressional leaders to create a regulatory framework for hemp-based intoxicating cannabinoids—rather than impose an outright ban. *— Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.* *Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. —* Meanwhile, bipartisan House lawmakers recently pushed back against attempts to ban hemp THC products, arguing that it would “deal a fatal blow” to the industry and, as currently included in a spending bill, violates congressional rules. To that end, the members say there are plans in the works to introduce an alternative measure to regulate the market. While the Senate ultimately stripped similar language from its version of the agriculture spending measure following a procedural protest from Sen. Rand Paul (R-KY), there’s still concern among stakeholders that it could wind up in the final package delivered to the president following bicameral negotiations. Dozens of hemp farmers from Kentucky also recently urged their state’s senior U.S. senator, Sen. Mitch McConnell (R-KY), to back off from his push to recriminalize some products that are derived from their crops. Paul, for his part, recently cautioned that the cannabis policy movement has “swung hard on the prohibitionist side” amid the ongoing debate over intoxicating hemp products. And he worries that, if things go awry, the hemp market could be decimated “within the next two weeks.” Asked about recent conversations with McConnell and Rep. Andy Harris (R-KY), Paul said “we’ve been working diligently” with the staff “trying to reach a compromise.” The post Major Alcohol Industry Trade Association Welcomes Its First THC Cannabis Beverage Member appeared first on Marijuana Moment. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

Decarboxylation is essential for enjoying cannabis, a process where carbon dioxide leaves a molecule, affecting its weight. Heating, light, and oxygen can cause this. The mass lost can be calculated if the initial and final weights are known. Decarboxylation is crucial for understanding cannabis as medicine, as it converts cannabinoid acids like THCA into THC. Most cannabinoids lose approximately 87.7% of their mass during decarboxylation. This is vital for those making edibles or advertising raw cannabis products, requiring accurate labeling. THC is the primary intoxicant and has therapeutic uses, while THCA is a strong anti-inflammatory. CBD aids with anxiety and breast cancer, and CBDA can slow the spread of breast cancer cells. CBG has anti-inflammatory properties for IBS. Mass loss isn't a conversion rate; it's a theoretical maximum, so labeling is important. < Back What You Need to Know About Decarboxylation Dec 17, 2024 Marco Troiani Cannabis Now Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Decarboxylation, which is an essential action in enjoying cannabis flowers and edibles, is a process in which carbon dioxide (CO2) leaves a stable molecule and floats off as a gas. Atoms in a molecule can be thought of like billiard balls, with each one having a size, weight, and exact position. As these atoms float away, the substance left behind will become lighter, like a dry towel being lighter than that same towel soaking wet. The idea is that as the CO2 leaves, the weight left behind is reduced. Decarboxylation typically occurs by heating, but can also be caused by exposure to certain frequencies of light, and certain substances like molecular oxygen in the air. If the weight of the molecule before and after its decarboxylation is known, then a percent of mass lost in decarboxylation can be calculated. If the CO2 contributes 10 percent of the weight of a molecule, than 90 percent of the mass remains after decarboxylation. This would mean that continuously heating 100 grams of this substance would eventually yield 90 grams of the decarboxylated substance, as the remaining 10 grams represent the weight of CO2 which gassed off. *How Does Decarboxylation Affect Cannabinoids?* Decarboxylation of cannabinoids and cannabis products is very crucial to understanding the power of cannabis as medicine. The cannabis plant only has the ability to produce cannabinoid acids, like THCA, and THC is only created by decarboxylation outside the plant. This decarboxylation is usually done by fire when smoking, or by baking in edibles. Most cannabinoids lose approximately 87.7 percent of their mass upon decarboxylation. This means that if you had 100 grams of crystalline isolate of a cannabinoid acid, such as THCA, after decarboxylation you would have 87.7 grams left of THC. This is important for people decarboxylating their cannabinoids themselves, such as producers of cannabis-infused edible products and hash oil producer that wish to sell decarboxylated oil. This is also important for advertisers of raw cannabis products such as cured cannabis flower, who must either report the value of the cannabinoid acid directly observed by the testing lab, use the theoretical conversion, or display both. This labeling issue with raw flower is not as easy as it seems at first glance. Let’s consider a typical example of THC-dominant cannabis. The lab will test the flower and find 26 percent THCA and 3 percent THC. This is because some of the cannabinoid acids produced by the plant are decarboxylated by air and sun before harvesting and curing. The smaller the amount of THC observed directly by the lab typically indicates that the cultivator has submitted fresh cannabis that has been protected from light and exposure. A very high THC content indicates that the cannabis flower is not as fresh and been more exposed. Now the dispensary has to either advertise two numbers, 26 percent and 3 percent, or advertise one theoretically calculated number, 25.8 percent, or both. Both allow the patient to access the greatest amount of information and be the best informed, while also reducing liability on the cannabis business involved in label making. Tetrahydrocannabinol (THC) is a well-known cannabinoid for being the primary intoxicant and euphoriant of cannabis. THC is also one of the most practical and safe treatments for neuropathic, chronic, and other types of pain. THC is effective in addressing both the immunological and symptom component of multiple sclerosis (MS). Despite the fact that THCA is not an intoxicant, it is a powerful medicine. THCA is one of the strongest anti-inflammatory agents in cannabis. Smokers receive very little to none of this cannabinoid, due to its decomposition in the smoking process. THCA is an anti-inflammatory agent, and according to one study, a more powerful neuroprotective agent than THC. THCA is a powerful COX-1 and COX-2 antagonist, similar to aspirin and ibuprofen, but with far less toxicity to the liver. The effects of THCA and THC reflect the diversity of action on the human body a cannabinoid and its precursor acid can have. The other cannabinoids, CBD, CBG, CBC, and THCV all have acid forms which have distinct effects on human health. *Cannabidiol* (CBD) has been shown to be an effective medicine for people suffering from anxiety. What CBD has also been shown to be effective at fighting is breast cancer cells. Many of these studies find that CBD promotes apoptosis, or cell suicide, in breast cancer cells while leaving the healthy cells unaffected. *Cannabidiolic acid* (CBDA) is CBD’s acid precursor from raw cannabis flower. CBDA has also been shown to fight human breast cancer, but in a different way. Whereas CBD causes apoptosis in breast cancer cells, CBDA has been shown to slow or stop metastasis of breast cancer cells by arresting their motility, or ability to move throughout the body. This evidence would indicate that a breast cancer patient may want to talk to their doctor about dual CBD/CBDA therapy, taking both decarboxylated CBD and raw CBDA together. *Cannabigerol* (CBG) has been shown to have some potent anti-inflammatory properties that are particularly applicable in inflammatory bowel disease (IBS). Additionally, CBG has been shown to have some properties not known among many other cannabinoids, such as an ability to interact with human adrenal receptors and serotonin receptors. Currently, more studies need to be done on cannabigerolic acid (CBGA) in isolation from CBG to get an understanding what, if any, difference there are between the cannabinoid and its precursor acid on human health. It is important to note that the mass loss is not a conversion rate. Mass loss assumes that all of a substance will decarboxylate and calculates how the mass will change. An accurate answer must account for how much of the cannabinoid will decarboxylate. Studies indicate that 30-70 percent of cannabinoids undergo decarboxylation under standard smoking conditions. This is why our calculations are only a theoretical maximum, and are not a result with the same standing as those directly observed in the plant. This is also why it can be very important to label your theoretical calculations as such, and provide all original values provided by lab results, as a means of reducing liability upon your business. The post What You Need to Know About Decarboxylation appeared first on Cannabis Now. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

The legalization of recreational marijuana is leading to the emergence of cannabis tourism as a new niche in the travel industry. < Back Cannabis industry is sparking a new era of tourism Jul 10, 2025 Margaret Jackson MJbizDaily Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link As more states and countries legalize recreational marijuana, a new niche in the travel industry is emerging: cannabis tourism. Cannabis industry is sparking a new era of tourism is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

With a wider House majority and the election of a pro-legalization governor, Virginia Democrats are optimistic about advancing legislation to create an adult-use marijuana market. State Senator Aaron Rouse (D) and Governor-elect Abigail Spanberger support the move, citing potential revenue for communities and public schools. Previous efforts to establish a commercial market were vetoed by outgoing Governor Glenn Youngkin (R). Spanberger supports a safe, transparent, and fair market that prioritizes public safety and economic growth. A legislative commission is also preparing a proposal for the full legislature to consider in the 2026 session. < Back Virginia Senator Is ‘Very Optimistic’ About Legalizing Marijuana Sales Under New Pro-Reform Governor Nov 11, 2025 Kyle Jaeger Marijuana Moment Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link With Virginia Democrats widening their House majority and voters electing a pro-legalization governor during last week’s election, one senator from the party says he’s “very optimistic” about the prospect of advancing legislation to create an adult-use marijuana market in the coming session. In an interview with 13 News Now that aired on Friday, Sen. Aaron Rouse (D) was asked about the prospects of moving forward with cannabis reform and finally implementing a commercial sales program years after the legislature legalized possession and home cultivation by adults. “Any measure that we can take to find revenue, I’m very optimistic about that approach,” the senator, who has been the lead sponsor of legislation to legalize and regulate adult-use sales that was vetoed by the outgoing GOP governor, said. “We, in Virginia, have to take every step we can to make sure we can find revenues that strengthen our communities, that strengthens the education process, that puts food on the table, that gets people back to work,” Rouse said. Since legalizing cannabis possession in 2021, Virginia lawmakers have worked to establish a commercial marijuana market—only to have those efforts consistently stalled under outgoing Gov. Glenn Youngkin (R), who twice vetoed measures to enact it that were sent to his desk by the legislature. This next session is shaping up to deliver different results. In addition to growing their majority in the Assembly, Democrats now have Abigail Spanberger as the state’s next governor, and the party also secured wins in the Commonwealth’s lieutenant governor and attorney general races. Spanberger, a former congresswoman, told Marijuana Moment ahead of the election that “as Virginia takes steps toward creating a legalized retail market for cannabis,” the commonwealth “needs a clear strategy to set up a market that is safe for consumers, transparent for businesses, and fair to entrepreneurs.” She added that “revenue from commercial cannabis products must return to Virginia communities and be reinvested for purposes like strengthening our public schools.” The governor-elect said she will “work with leaders in the General Assembly to find a path forward that both prioritizes public safety and grows Virginia’s economy”—and that part of that is establishing “a formalized, legal, emerging cannabis market.” During her time in Congress, Spanberger voted twice on the House floor in support of bills to federally legalize marijuana. She also consistently backed legislation to free up banking services for the industry, protect all state cannabis program from federal interference and expand marijuana research. The former congresswoman additionally opposed a proposal to remove protections for universities that study cannabis. She voted against certain reform proposals, however, including on measures to lift certain research barriers for Schedule I drugs and to revise federal policy to prevent past marijuana use from being used as a factor to determine eligibility for a security clearance. Spanberger cosponsored bills to provide medical cannabis access for military veterans on two occasions, and she cosponsored the Secure and Fair Enforcement (SAFE) Banking Act during the 116th Congress. *— Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.* *Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. —* In recent months, a Virginia legislative commission has been discussing plans to prepare the state to legalize recreational marijuana sales. Del. Paul Krizek (D), chair of the Joint Commission to Oversee the Transition of the Commonwealth into a Cannabis Retail Market, began the most recent meeting last month by noting it would be the second-to-last for the body—saying that at the next and final one in December, members will “go over the bill that we are working on now.” The plan is for the body to suggest a proposal that the full legislature can consider passing in the 2026 session that begins in January. At the legislative commission’s first meeting in July, members discussing broad regulatory considerations and other issues related to THC potency, the hemp market and more. In August, the panel focused on cannabis taxes and revenue. Meanwhile, a top Democratic Virginia senator recently said the state should move forward with legalizing recreational marijuana sales—in part to offset the Trump administration’s cuts to federal spending in support of states. *Photo courtesy of Mike Latimer.* The post Virginia Senator Is ‘Very Optimistic’ About Legalizing Marijuana Sales Under New Pro-Reform Governor appeared first on Marijuana Moment. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

A leader in innovative horticulture lighting solutions, the company was recognized at the council’s annual Industry Awards Celebration. < Back JumpLights Wins Maryland Tech Council’s Emerging Technology Company of the Year ICON Award Jun 4, 2025 Cannabis Business Times Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link A leader in innovative horticulture lighting solutions, the company was recognized at the council’s annual Industry Awards Celebration. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

Cannabis and hemp growers and experts discuss their methods for combating various pest threats such as aphids, grasshoppers, and mites. < Back How to Protect Your Outdoor Cannabis Crops From Pests Sep 15, 2025 Cannabis Business Times Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Cannabis and hemp growers, experts share how they battle pest threats, from aphids and grasshoppers to mites, and more. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

California cannabis regulators have issued a voluntary recall for several THC-infused beverages due to noncompliant labeling and packaging. This recall was posted on MJBizDaily, a news source for cannabis entrepreneurs. < Back California cannabis regulators recall THC beverages Sep 16, 2025 Margaret Jackson MJbizDaily Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link California cannabis regulators issued a voluntary recall for multiple THC-infused beverages because of noncompliant labeling and packaging. California cannabis regulators recall THC beverages is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

New cannabis companies face challenges including limited funding, complex regulations, and market competition. Social equity programs often fall short. Policy reforms at the state and federal levels are needed to address these barriers. < Back Why New Cannabis Companies Face High Barriers to Entry in 2025 Jun 2, 2025 Staff Mary Jane Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Despite the expanding legalization of cannabis across the United States, new entrants to the industry encounter significant challenges that hinder their ability to establish and grow successful businesses. These barriers include limited access to financing, complex regulatory landscapes, and intense competition from established players. *Financial Hurdles and Limited Access to Capital* Securing funding remains a primary obstacle for new cannabis entrepreneurs. Traditional banks and financial institutions often hesitate to provide services to cannabis businesses due to the federal classification of marijuana as a Schedule I substance. This reluctance forces many startups to rely on private lenders or personal savings, which may be insufficient to cover the substantial costs associated with launching a cannabis operation. These costs include licensing fees, real estate, compliance measures, and initial inventory. *Regulatory Complexities and Compliance Costs* Navigating the regulatory environment is another significant challenge. Cannabis laws vary widely between states, and even within states, local jurisdictions may have their own rules and restrictions. Compliance with these regulations requires substantial time and resources, including legal counsel and specialized consultants. Failure to adhere strictly to these laws can result in fines, license revocations, or legal action, posing a constant risk to new businesses. *Market Saturation and Competition* The cannabis market has become increasingly saturated, particularly in states where legalization occurred early. Established companies with significant capital and brand recognition dominate the market, making it difficult for new entrants to gain a foothold. These incumbents benefit from economies of scale, established distribution networks, and customer loyalty, which new businesses struggle to match. *Social Equity Initiatives and Their Limitations* While many states have implemented social equity programs aimed at assisting individuals from communities disproportionately affected by past cannabis prohibitions, these initiatives often fall short. Applicants may receive priority in licensing but still face the same financial and regulatory challenges as other entrants. Without adequate support, such as access to capital and business development resources, these programs may not effectively level the playing field. *The Path Forward* Addressing these barriers requires comprehensive policy reforms at both the state and federal levels. Federal legalization or reclassification of cannabis could open doors to traditional banking services, reducing financial constraints. Streamlining regulatory processes and providing targeted support to new entrants, particularly those from marginalized communities, can foster a more inclusive and competitive industry. The post Why New Cannabis Companies Face High Barriers to Entry in 2025 appeared first on Merry Jane. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

A government-funded study found that state agencies regulating marijuana largely outperform alcohol regulatory agencies concerning public health goals, activities, and policies. The analysis showed 68 percent of cannabis regulators referenced public health goals in their mission statements, compared to only 35 percent of alcohol regulators, suggesting marijuana is currently regulated more robustly than alcohol regarding key public health measures. < Back Marijuana Regulations Protect Public Health Better Than Alcohol Rules Do, New Government-Funded Study Finds Dec 3, 2025 Aaron Houston Marijuana Moment Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link State agencies that regulate marijuana are far more attentive to public health concerns than the those charged with overseeing alcohol, a new government-funded study has concluded. “Cannabis regulatory agencies largely outperform alcohol regulatory agencies in terms of their articulated public health goals, activities, and policies,” the authors, all affiliated with the University of Maryland, wrote. For the study, researchers analyzed recent annual reports from state regulatory agencies in all 24 U.S. states where adult use cannabis is legal as of mid-2025. They compared how cannabis and alcohol regulatory agencies outlined their goals, reported collaboration with health agencies and described activities aimed at improving public health and safety. According to the analysis, 68 percent of cannabis regulatory agencies referenced public health goals in their mission statements, compared with just 35 percent of those that oversee alcohol. As some campaigns to legalize recreational cannabis swept through state ballots over the last decade, “regulate marijuana like alcohol” was a common refrain—but the new study suggests that in practice, marijuana is now being regulated more robustly than alcohol when it comes to key public health measures. The authors also observed differences in outcomes among states, depending on the manner in which marijuana legalization was achieved. “Compared to states that legalized adult-use cannabis through ballot initiatives, states that legalized through their legislatures reported more public health indicators for both cannabis and alcohol regulators,” they wrote. The paper also notes that while the initial wave of laws ending marijuana prohibition were passed via voter initiatives, “states adopting adult-use cannabis legalization more recently have predominantly legalized through their state legislatures and have cannabis regulators that report on a greater number of cannabis-related public health issues.” Regardless of the method of legalization, the researchers, who are affiliated with the Department of Criminology and Criminal Justice at the University of Maryland, concluded that “adult-use cannabis regulatory agencies reported all public health indicators more often, while alcohol regulatory agencies reported engaging in law enforcement efforts more often than cannabis regulators.” The study was funded by a grant from the California Department of Cannabis Control and published in the December 2025 edition of the scientific journal International Journal of Drug Policy. The authors caution that further investigation would be beneficial in understanding the differences among state regulations. “More research is needed to assess whether public health-related actions reported by cannabis agencies translate into tangible public health benefits among cannabis using and affected populations,” they wrote. The new study comes as members of Congress have teamed up across the aisle to prepare the federal government to regulate marijuana like alcohol. One bill that has been introduced in the House would direct the attorney general to create a commission charged with making recommendations on a regulatory system for cannabis that models what is currently in place for alcohol. It also comes at a time when a coalition of leading alcohol industry groups successfully urged Congress to impose a ban on intoxicating hemp products—though they said they would ultimately like federal officials develop a comprehensive regulatory framework for the products. Additionally, the study comes on the heels of a GOP senator saying in June that opponents of marijuana legalization “have lost” the fight to maintain prohibition and that it’s time for lawmakers to address that reality by creating a regulatory framework treating cannabis “in the same way that we do with alcohol and tobacco,” so that states can set their own policies without federal interference. The post Marijuana Regulations Protect Public Health Better Than Alcohol Rules Do, New Government-Funded Study Finds appeared first on Marijuana Moment. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5

Get ready for MARY FEST! New York’s premier cannabis & culture festival kicks off April 20 with activities, infused treats & more. The post Celebrate 420 weekend with cannabis, community, and creativity at MARY FEST NYC appeared first on Leafly. < Back Celebrate 420 weekend with cannabis, community, and creativity at MARY FEST NYC Apr 10, 2025 Leafly Staff Leafly Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Get ready for MARY FEST! New York’s premier cannabis & culture festival kicks off April 20 with activities, infused treats & more. The post Celebrate 420 weekend with cannabis, community, and creativity at MARY FEST NYC appeared first on Leafly. < Previous Next > Recent Reviews Cake Boss - Fluent, Clearwater (Florida Medical) Cake Boss, available at Fluent dispensary in Clearwater, Florida, is a slightly indica-dominant hybrid strain (60% indica, 40% sativa) th... Cherry AK-47 by Grow West - RISE Dispensary (Silver Spring, Maryland) When a strain name includes both "Cherry" and "AK-47," you can expect two things: a blast of fruity goodness and the kind of impact that... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5